5 Patents
- 0 cites
- US123647452025Immunogenicity of a Cpg-adjuvanted Recombinant Plague Vaccine
The Government Of The United States, As Represented By The Secretary Of The Army
0 cites - US122960022025Immunogenic Composition Against Severe Acute Respiratory Syndrome Coronavirus 2 (sars-cov-2)
DYNAVAX TECHNOLOGIES CORPORATION
0 cites - US119186482024Combination of a PD-1 Antagonist and Cpg-c Type Oligonucleotide for Treating Cancer
TRISALUS LIFE SCIENCES, Inc.
0 cites - 0 cites